A detailed history of Wellington Shields & Co., LLC transactions in Baxter International Inc stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 14,268 shares of BAX stock, worth $555,167. This represents 0.16% of its overall portfolio holdings.

Number of Shares
14,268
Previous 14,250 0.13%
Holding current value
$555,167
Previous $609,000 21.67%
% of portfolio
0.16%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$32.87 - $43.55 $591 - $783
18 Added 0.13%
14,268 $477,000
Q1 2024

May 23, 2024

BUY
$37.88 - $43.77 $387,171 - $447,373
10,221 Added 253.69%
14,250 $609,000
Q1 2024

May 23, 2024

SELL
$37.88 - $43.77 $387,171 - $447,373
-10,221 Reduced 71.73%
4,029 $172,000
Q1 2024

May 03, 2024

BUY
$37.88 - $43.77 $387,171 - $447,373
10,221 Added 253.69%
14,250 $609,000
Q4 2023

Feb 09, 2024

BUY
$31.71 - $38.95 $665 - $817
21 Added 0.52%
4,029 $155,000
Q3 2023

Nov 14, 2023

BUY
$37.32 - $49.29 $298 - $394
8 Added 0.2%
4,008 $151,000
Q3 2021

Nov 10, 2021

SELL
$73.77 - $83.61 $11,065 - $12,541
-150 Reduced 3.61%
4,000 $322,000
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $161,000 - $176,020
-2,000 Reduced 32.52%
4,150 $334,000
Q4 2019

Feb 11, 2020

BUY
$76.7 - $88.45 $23,010 - $26,535
300 Added 5.13%
6,150 $514,000
Q3 2019

Nov 05, 2019

SELL
$81.4 - $89.78 $24,420 - $26,934
-300 Reduced 4.88%
5,850 $512,000
Q1 2019

May 10, 2019

SELL
$64.48 - $81.31 $154,752 - $195,144
-2,400 Reduced 28.07%
6,150 $500,000
Q3 2018

Nov 06, 2018

SELL
$70.71 - $77.75 $17,677 - $19,437
-250 Reduced 2.84%
8,550 $659,000
Q3 2017

Nov 06, 2017

BUY
$59.5 - $64.61 $523,600 - $568,568
8,800
8,800 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.